Ovoca Bio Investor Relations Material
Latest events
H2 2024
26 Jun, 2025
H1 2024
25 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ovoca Bio plc
Access all reports
Ovoca Bio plc is a clinical-stage biopharmaceutical company focusing on women's health. The company is actively involved in developing novel therapeutic products, particularly targeting female sexual dysfunction. Its lead candidate, a treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women, is under clinical development. Ovoca Bio's research and development efforts are geared towards addressing unmet medical needs in this area. The company is headquartered in Dublin, Ireland, and its shares are listed on the Euronext Dublin.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
OVXA
Country
🇮🇪 Ireland